INSM FY 2025 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$606M+66.7% YoY

Gross Profit

$482M79.4% margin

Operating Income

-$1.2B-194.0% margin

Net Income

-$1.3B-210.5% margin

EPS (Diluted)

$-6.41

Cash Flow

Operating Cash Flow

-$935M

Free Cash Flow

-$968M

Stock-Based Comp.

$153M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$1.5B

Stockholders' Equity

$739M

Cash & Equivalents

$510M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$606M	$364M	+66.7%
Gross Profit	$482M	$278M	+73.2%
Operating Income	-$1.2B	-$878M	-34.0%
Net Income	-$1.3B	-$914M	-39.7%